BeiGene Ltd.

NASDAQ: BGNE · Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 10:00 PM

BeiGene Statistics

Share Statistics

BeiGene has 109.41M shares outstanding. The number of shares has increased by -2.01% in one year.

109.41M
-2.01%
0%
3.06%
57.61M
986
0.28%

Short Selling Information

The latest short interest is 1.31M, so 0% of the outstanding shares have been sold short.

1.31M
n/a
n/a
4.36

Valuation Ratios

The PE ratio is -30.02 and the forward PE ratio is 53.69. BeiGene's PEG ratio is -0.04.

-30.02
53.69
5.08
3.6
5.81
-28.9
-0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BeiGene.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.8, with a Debt / Equity ratio of 0.32.

1.8
1.58
0.32
-2.72
-1.61
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$359.46K
$-60.83K
10,600
0.64
1.2

Taxes

111.78M
-20.97%

Stock Price Statistics

The stock price has increased by -2.8% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been higher than the market average.

0.63
-2.8%
194.34
182.89
77.12
357,765

Income Statement

In the last 12 months, BeiGene had revenue of 3.81B and earned -644.79M in profits. Earnings per share was -79.43.

3.81B
3.22B
-568.2M
-644.79M
-396.44M
-568.2M
-79.43
Full Income Statement

Balance Sheet

The company has 2.63B in cash and 1.08B in debt, giving a net cash position of 1.55B.

2.63B
1.08B
1.55B
-8.61B
5.84B
1.91B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -140.63M and capital expenditures -529.14M, giving a free cash flow of -669.77M.

-140.63M
-529.14M
-669.77M
-6.39
Full Cash Flow Statement

Margins

Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.

84.41%
-14.91%
-13.99%
-16.92%
-10.4%
-14.91%
-17.58%

Dividends & Yields

BGNE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BGNE is $274, which is 48.3% higher than the current price. The consensus rating is "Strong Buy".

$274
48.3%
Strong Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

4.06
4